Progyny Analyst Ratings
Progyny Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/09/2023 | 69.09% | JP Morgan | $58 → $57 | Maintains | Overweight |
| 09/27/2023 | 36.46% | Canaccord Genuity | → $46 | Initiates Coverage On | → Buy |
| 09/14/2023 | 42.39% | Cantor Fitzgerald | $45 → $48 | Maintains | Overweight |
| 08/11/2023 | 54.26% | Truist Securities | $48 → $52 | Maintains | Buy |
| 08/04/2023 | 48.32% | Keybanc | $45 → $50 | Maintains | Overweight |
| 05/22/2023 | 48.32% | BTIG | → $50 | Initiates Coverage On | → Buy |
| 05/15/2023 | 72.06% | JP Morgan | $61 → $58 | Maintains | Overweight |
| 05/09/2023 | 48.32% | B of A Securities | $40 → $50 | Maintains | Buy |
| 05/09/2023 | 33.49% | Cantor Fitzgerald | $44 → $45 | Maintains | Overweight |
| 04/21/2023 | 30.53% | Cantor Fitzgerald | → $44 | Initiates Coverage On | → Overweight |
| 01/05/2023 | 0.86% | SVB Leerink | $59 → $34 | Downgrades | Outperform → Market Perform |
| 12/19/2022 | 33.49% | Keybanc | $55 → $45 | Maintains | Overweight |
| 11/18/2022 | 83.92% | JP Morgan | $78 → $62 | Maintains | Overweight |
| 09/16/2022 | 63.16% | Keybanc | → $55 | Maintains | Overweight |
| 09/07/2022 | 66.12% | Truist Securities | → $56 | Initiates Coverage On | → Buy |
| 12/02/2021 | 77.99% | Jefferies | → $60 | Initiates Coverage On | → Buy |
| 09/30/2021 | 140.28% | Berenberg | → $81 | Initiates Coverage On | → Buy |
| 09/28/2021 | 137.32% | Barclays | $72 → $80 | Maintains | Overweight |
| 08/25/2021 | 113.59% | Barclays | $64 → $72 | Maintains | Overweight |
| 08/12/2021 | 89.85% | Barclays | → $64 | Initiates Coverage On | → Overweight |
| 08/06/2021 | 75.02% | SVB Leerink | $64 → $59 | Maintains | Outperform |
| 06/02/2021 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 05/07/2021 | 89.85% | SVB Leerink | $58 → $64 | Maintains | Outperform |
| 03/10/2021 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 11/25/2020 | 3.83% | B of A Securities | $30 → $35 | Maintains | Neutral |
| 11/06/2020 | 48.32% | SVB Leerink | $44 → $50 | Maintains | Outperform |
| 08/24/2020 | 3.83% | JP Morgan | $30 → $35 | Maintains | Overweight |
| 08/06/2020 | -2.11% | Piper Sandler | $32 → $33 | Maintains | Overweight |
| 08/06/2020 | 30.53% | SVB Leerink | $35 → $44 | Maintains | Outperform |
| 08/06/2020 | -5.07% | Citigroup | $28 → $32 | Maintains | Buy |
| 07/27/2020 | -16.94% | B of A Securities | $26 → $28 | Maintains | Neutral |
| 07/01/2020 | 3.83% | SVB Leerink | → $35 | Initiates Coverage On | → Outperform |
| 06/02/2020 | -11.01% | Guggenheim | → $30 | Initiates Coverage On | → Buy |
| 05/13/2020 | -16.94% | Citigroup | $29 → $28 | Maintains | Buy |
| 03/10/2020 | -13.97% | Citigroup | $30 → $29 | Maintains | Buy |
| 12/04/2019 | -16.94% | B of A Securities | $26 → $28 | Reiterates | → Neutral |
| 11/19/2019 | -22.87% | JP Morgan | → $26 | Initiates Coverage On | → Overweight |
| 11/19/2019 | -16.94% | SVB Leerink | → $28 | Initiates Coverage On | → Outperform |
| 11/19/2019 | -11.01% | Citigroup | → $30 | Initiates Coverage On | → Buy |
| 11/19/2019 | -2.11% | Piper Sandler | → $33 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/09/2023 | 69.09% | 摩根大通 | $58→$57 | 維護 | 超重 |
| 09/27/2023 | 36.46% | 卡納科特·格納奇 | →$46 | 開始承保 | →購買 |
| 09/14/2023 | 42.39% | 康託·菲茨傑拉德 | $45→$48 | 維護 | 超重 |
| 2023年08月11日 | 54.26% | Truist證券 | $48→$52 | 維護 | 買 |
| 08/04/2023 | 48.32% | KeyBanc | $45→$50 | 維護 | 超重 |
| 2023年05月22日 | 48.32% | BTIG | →$50 | 開始承保 | →購買 |
| 2023年05月15日 | 72.06% | 摩根大通 | $61→$58 | 維護 | 超重 |
| 05/09/2023 | 48.32% | B of A證券 | $40→$50 | 維護 | 買 |
| 05/09/2023 | 33.49% | 康託·菲茨傑拉德 | $44→$45 | 維護 | 超重 |
| 04/21/2023 | 30.53% | 康託·菲茨傑拉德 | →$44 | 開始承保 | →超重 |
| 01/05/2023 | 0.86% | SVB Leerink | $59→$34 | 評級下調 | 跑贏→市場表現 |
| 2022年12月19日 | 33.49% | KeyBanc | $55→$45 | 維護 | 超重 |
| 2022年11月18日 | 83.92% | 摩根大通 | $78→$62 | 維護 | 超重 |
| 09/16/2022 | 63.16% | KeyBanc | →$55 | 維護 | 超重 |
| 09/07/2022 | 66.12% | Truist證券 | →$56 | 開始承保 | →購買 |
| 12/02/2021 | 77.99% | 傑富瑞 | →$60 | 開始承保 | →購買 |
| 09/30/2021 | 140.28% | 貝倫伯格 | →$81 | 開始承保 | →購買 |
| 09/28/2021 | 137.32% | 巴克萊 | $72→$80 | 維護 | 超重 |
| 2021/08/25 | 113.59% | 巴克萊 | $64→$72 | 維護 | 超重 |
| 2021/08/12 | 89.85% | 巴克萊 | →$64 | 開始承保 | →超重 |
| 08/06/2021 | 75.02% | SVB Leerink | $64→$59 | 維護 | 跑贏大盤 |
| 06/02/2021 | - | 古根海姆 | 評級下調 | 購買→中性 | |
| 05/07/2021 | 89.85% | SVB Leerink | $58→$64 | 維護 | 跑贏大盤 |
| 03/10/2021 | - | B of A證券 | 升級 | 中性→購買 | |
| 11/25/2020 | 3.83% | B of A證券 | $30→$35 | 維護 | 中性 |
| 11/06/2020 | 48.32% | SVB Leerink | $44→$50 | 維護 | 跑贏大盤 |
| 08/24/2020 | 3.83% | 摩根大通 | $30→$35 | 維護 | 超重 |
| 08/06/2020 | -2.11% | 派珀·桑德勒 | $32→$33 | 維護 | 超重 |
| 08/06/2020 | 30.53% | SVB Leerink | $35→$44 | 維護 | 跑贏大盤 |
| 08/06/2020 | -5.07% | 花旗集團 | $28→$32 | 維護 | 買 |
| 07/27/2020 | -16.94% | B of A證券 | $26→$28 | 維護 | 中性 |
| 07/01/2020 | 3.83% | SVB Leerink | →$35 | 開始承保 | →跑贏大盤 |
| 06/02/2020 | -11.01% | 古根海姆 | →$30 | 開始承保 | →購買 |
| 2020/05/13 | -16.94% | 花旗集團 | $29→$28 | 維護 | 買 |
| 03/10/2020 | -13.97% | 花旗集團 | $30→$29 | 維護 | 買 |
| 2019/12/04 | -16.94% | B of A證券 | $26→$28 | 重申 | →中性 |
| 2019年11月19日 | -22.87% | 摩根大通 | →$26 | 開始承保 | →超重 |
| 2019年11月19日 | -16.94% | SVB Leerink | →$28 | 開始承保 | →跑贏大盤 |
| 2019年11月19日 | -11.01% | 花旗集團 | →$30 | 開始承保 | →購買 |
| 2019年11月19日 | -2.11% | 派珀·桑德勒 | →$33 | 開始承保 | →超重 |
What is the target price for Progyny (PGNY)?
普羅吉尼(Progyny)的目標價是多少？
The latest price target for Progyny (NASDAQ: PGNY) was reported by JP Morgan on October 9, 2023. The analyst firm set a price target for $57.00 expecting PGNY to rise to within 12 months (a possible 69.09% upside). 13 analyst firms have reported ratings in the last year.
摩根大通於2023年10月9日報道了Progyny(納斯達克代碼：PGNY)的最新目標價。這家分析公司將目標價定為57.00美元，預計PGNY將在12個月內上漲(可能上漲69.09%)。過去一年，有13家分析公司公佈了評級。
What is the most recent analyst rating for Progyny (PGNY)?
分析師對Progyny的最新評級是多少？
The latest analyst rating for Progyny (NASDAQ: PGNY) was provided by JP Morgan, and Progyny maintained their overweight rating.
納斯達克(Sequoia Capital：PGNY)的最新分析師評級由摩根大通提供，普羅吉尼維持增持評級。
When is the next analyst rating going to be posted or updated for Progyny (PGNY)?
Progyny(PGNY)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Progyny, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Progyny was filed on October 9, 2023 so you should expect the next rating to be made available sometime around October 9, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Progyny的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Progyny的上一次評級是在2023年10月9日提交的，所以你應該預計下一次評級將在2024年10月9日左右提供。
Is the Analyst Rating Progyny (PGNY) correct?
分析師評級展望(PGNY)正確嗎？
While ratings are subjective and will change, the latest Progyny (PGNY) rating was a maintained with a price target of $58.00 to $57.00. The current price Progyny (PGNY) is trading at is $33.71, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Progyny(PGNY)評級維持不變，目標價在58.00美元至57.00美元之間。目前Progyny的交易價格為33.71美元，超出了分析師的預測區間。